File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: A phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population

TitleA phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population
Authors
Gane, ESchwabe, CGiven, BSchluep, THamilton, JLai, CLLocarnini, SLau, JFerrari, CGish, R
Issue Date2017
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
The International Liver Congress 2017 (ILC 2017) — 52nd Annual Meeting of the European Association for the Study of the Liver (EASL). Amsterdam, The Netherlands, 19–23 April 2017. In Journal of Hepatology, 2017, v. 66 n. 1 Suppl, p. S265 How to Cite?
DOI: http://dx.doi.org/10.1016/S0168-8278(17)30843-7
Persistent Identifierhttp://hdl.handle.net/10722/246334
ISSN
0168-8278
2021 Impact Factor: 30.083
2020 SCImago Journal Rankings: 7.112
ISI Accession Number ID
WOS:000401056600580

 

DC FieldValueLanguage
dc.contributor.authorGane, E-
dc.contributor.authorSchwabe, C-
dc.contributor.authorGiven, B-
dc.contributor.authorSchluep, T-
dc.contributor.authorHamilton, J-
dc.contributor.authorLai, CL-
dc.contributor.authorLocarnini, S-
dc.contributor.authorLau, J-
dc.contributor.authorFerrari, C-
dc.contributor.authorGish, R-
dc.date.accessioned2017-09-18T02:26:41Z-
dc.date.available2017-09-18T02:26:41Z-
dc.date.issued2017-
dc.identifier.citationThe International Liver Congress 2017 (ILC 2017) — 52nd Annual Meeting of the European Association for the Study of the Liver (EASL). Amsterdam, The Netherlands, 19–23 April 2017. In Journal of Hepatology, 2017, v. 66 n. 1 Suppl, p. S265-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/246334-
dc.languageeng-
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep-
dc.relation.ispartofJournal of Hepatology-
dc.rightsPosting accepted manuscript (postprint): © <year>. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.titleA phase 1 study to evaluate safety and tolerability of escalating single doses of the hepatitis B virus RNA interference drug ARC-521 in a healthy volunteer population-
dc.typeConference_Paper-
dc.identifier.emailLai, CL: hrmelcl@hkucc.hku.hk-
dc.identifier.authorityLai, CL=rp00314-
dc.identifier.doi10.1016/S0168-8278(17)30843-7-
dc.identifier.hkuros278525-
dc.identifier.volume66-
dc.identifier.issue1 Suppl-
dc.identifier.spageS265-
dc.identifier.epageS265-
dc.identifier.isiWOS:000401056600580-
dc.publisher.placeNetherlands-
dc.identifier.issnl0168-8278-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats